Switch to: References

Add citations

You must login to add citations.
  1. To pay or not to pay? handling crowdsourced participants who drop out from a research study.Raquel Benbunan-Fich - 2023 - Ethics and Information Technology 25 (3):1-14.
    This article examines whether a crowdsourced research participant who quits a study before its completion should receive any monetary compensation. The study is focused on participants recruited from Amazon Mechanical Turk, the most widely used crowdsourcing platform, and examines the tensions between participants’ rights and research objectives when online labor markets are used to recruit research participants. The discussion is informed by the recent literature on online research with crowdsourced samples, evidence from human subjects’ practices at top US universities, and (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • The right to withdraw from controlled human infection studies: Justifications and avoidance.Holly Fernandez Lynch - 2020 - Bioethics 34 (8):833-848.
    The right to withdraw from research without penalty is well established around the world. However, it has been challenged in some corners of bioethics based on concerns about various harms—to participants, to scientific integrity, and to research bystanders—that may stem from withdrawal. These concerns have become particularly salient in emerging debates about the ethics of controlled human infection (CHI) studies in which participants are intentionally infected with pathogens, often in inpatient settings with extensive follow‐up. In this article, I provide support (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • (1 other version)The Right to Withdraw from Research.G. Owen Schaefer & Alan Wertheimer - 2010 - Kennedy Institute of Ethics Journal 20 (4):329-352.
    The right to withdraw from participation in research is recognized in virtually all national and international guidelines for research on human subjects. It is therefore surprising that there has been little justification for that right in the literature. We argue that the right to withdraw should protect research participants from information imbalance, inability to hedge, inherent uncertainty, and untoward bodily invasion, and it serves to bolster public trust in the research enterprise. Although this argument is not radical, it provides a (...)
    Download  
     
    Export citation  
     
    Bookmark   12 citations  
  • Comprehension of informed consent and voluntary participation in registration cohorts for phase IIb HIV vaccine trial in Dar Es Salaam, Tanzania: a qualitative descriptive study.Edith A. M. Tarimo & Masunga K. Iseselo - 2024 - BMC Medical Ethics 25 (1):1-13.
    BackgroundInformed consent as stipulated in regulatory human research guidelines requires volunteers to be well-informed about what will happen to them in a trial. However, researchers may be faced with the challenge of how to ensure that a volunteer agreeing to take part in a clinical trial is truly informed. This study aimed to find out volunteers’ comprehension of informed consent and voluntary participation in Human Immunodeficiency Virus (HIV) clinical trials during the registration cohort.MethodsWe conducted a qualitative study among volunteers who (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy.Euzebiusz Jamrozik & Michael J. Selgelid - 2020 - Journal of Medical Ethics 46 (9):601-609.
    Human infection challenge studies (HCS) involve intentionally infecting research participants with pathogens (or other micro-organisms). There have been recent calls for more HCS to be conducted in low-income and middle-income countries (LMICs), where many relevant diseases are endemic. HCS in general, and HCS in LMICs in particular, raise numerous ethical issues. This paper summarises the findings of a project that explored ethical and regulatory issues related to LMIC HCS via (i) a review of relevant literature and (ii) 45 qualitative interviews (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  • The Role, Remit and Function of the Research Ethics Committee — 3. Balancing Potential Social Benefits against Risks to Subjects.Sarah J. L. Edwards - 2010 - Research Ethics 6 (3):96-100.
    This is the third in a series of five papers on the role, remit and function of research ethics committees which are intended to provide for REC members a broad understanding of the most important issues in research ethics and governance. This paper examines the role of ethics committees in balancing the social value of the research it reviews against the risks it imposes on those who take part. The ethics committee's role in assessing the social value of research goes (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  • Assessing the Remedy: The Case for Contracts in Clinical Trials.Sarah J. L. Edwards - 2011 - American Journal of Bioethics 11 (4):3-12.
    Current orthodoxy in research ethics assumes that subjects of clinical trials reserve rights to withdraw at any time and without giving any reason. This view sees the right to withdraw as a simple extension of the right to refuse to participate all together. In this paper, however, I suggest that subjects should assume some responsibilities for the internal validity of the trial at consent and that these responsibilities should be captured by contract. This would allow the researcher to impose a (...)
    Download  
     
    Export citation  
     
    Bookmark   15 citations  
  • Should Patient Groups Have the Power to Redirect How Their Samples Are Used?Eleanor T. Chung & Benjamin E. Berkman - 2019 - American Journal of Bioethics 19 (8):26-28.
    The authors of the target article briefly discuss the issue of “sample ownership” when scientists collaborate with citizen science partners (Wiggins and Wilbanks 2019). This is an important issue,...
    Download  
     
    Export citation  
     
    Bookmark  
  • Reassessing the Role of the Biomedical Research Ethics Committee.Merryn Ekberg - 2012 - Journal of Academic Ethics 10 (4):335-352.
    The role of the Research Ethics Committee (REC) in the design, conduct and dissemination of scientific research is still evolving and many important questions remain unanswered. Hence, the aim of this paper is to address some of the uncertainty that exists around the role and responsibilities of RECs and to discuss some of the controversy that exists over the criteria that RECs should follow when evaluating a research proposal. The discussion is organised around five of the major roles currently performed (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • Views on the right to withdraw from randomised controlled trials assessing quality of life after mastectomy and breast reconstruction (QUEST): findings from the QUEST perspectives study (QPS).N. Bidad, L. MacDonald, Z. E. Winters, S. J. L. Edwards & R. Horne - 2014 - Research Ethics 10 (1):47-57.
    The purpose of this study is to examine the importance that real patients attach to their right to withdraw from an on-going feasibility randomised trial (RCT) evaluating types and timings of breast reconstruction (two parallel trials) following mastectomy for breast cancer. Our results show that, while some respondents appreciated that exercising the right to withdraw would defeat the scientific objective of the trial, some patients with a surgical preference consented only given the knowledge they could withdraw if they were not (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Efficacy Testing as a Primary Purpose of Phase 1 Clinical Trials: Is it Applicable to First-in-Human Bionics and Optogenetics Trials?Frederic Gilbert, Alexander R. Harris & Robert M. I. Kapsa - 2012 - American Journal of Bioethics Neuroscience 3 (2):20-22.
    In her article, Pascale Hess raises the issue of whether her proposed model may be extrapolated and applied to clinical research fields other than stem cell-based interventions in the brain (SCBI-B) (Hess 2012). Broadly summarized, Hess’s model suggests prioritizing efficacy over safety in phase 1 trials involving irreversible interventions in the brain, when clinical criteria meet the appropriate population suffering from “degenerative brain diseases” (Hess 2012). Although there is a need to reconsider the traditional phase 1 model, especially with respect (...)
    Download  
     
    Export citation  
     
    Bookmark   8 citations  
  • Against the inalienable right to withdraw from research.Eric Chwang - 2008 - Bioethics 22 (7):370-378.
    In this paper I argue, against the current consensus, that the right to withdraw from research is sometimes alienable. In other words, research subjects are sometimes morally permitted to waive their right to withdraw. The argument proceeds in three major steps. In the first step, I argue that rights typically should be presumed alienable, both because that is not illegitimately coercive and because the general paternalistic motivation for keeping them inalienable is untenable. In the second step of the argument, I (...)
    Download  
     
    Export citation  
     
    Bookmark   8 citations  
  • Response to Open Peer Commentaries on “Assessing the Remedy: The Case for Contracts in Clinical Trials”.Sarah J. L. Edwards - 2011 - American Journal of Bioethics 11 (4):W1-W3.
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • The evolution of withdrawal: negotiating research relationships in biobanking.Karen Melham, Linda Briceno Moraia, Colin Mitchell, Michael Morrison, Harriet Teare & Jane Kaye - 2014 - Life Sciences, Society and Policy 10 (1).
    The right to withdraw from research, along with the necessity of adequately informed consent, is at the heart of the post-Nuremburg code of ethical safeguards in biomedical research on human participants. As biomedical research moves away from direct interventional studies towards research using networks of linked human tissue samples and data, however, questions arise about what withdrawal can and should mean in these new contexts. Some of the more expansive traditional understandings, such as the right to withdraw from a study (...)
    Download  
     
    Export citation  
     
    Bookmark   6 citations  
  • Participants' responsibilities in clinical research.David B. Resnik & Elizabeth Ness - 2012 - Journal of Medical Ethics 38 (12):746-750.
    Discussions on the ethics and regulation of clinical research have a great deal to say about the responsibilities of investigators, sponsors, research institutions and institutional review boards, but very little about the responsibilities of research participants. In this article, we discuss the responsibilities of participants in clinical research. We argue that competent adult participants are responsible for complying with study requirements and fulfilling other obligations they undertake when they make an informed choice to enrol in a study. These responsibilities are (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  • Withdrawing from Research: A Rethink in the Context of Research Biobanks. [REVIEW]Søren Holm - 2011 - Health Care Analysis 19 (3):269-281.
    It is generally assumed in research ethics that research participants have an unconditional right to withdraw from research without any detriment or reprisal. This paper analyses this right in the context of biobank research and argues that the traditional shape of the right in clinical research can be modified in biobank research without incurring significant ethical cost. The paper falls in three parts. The first part is a brief explication of the philosophical justification of the right to withdraw. The second (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations